| Product Name | MF | CAS | Details |
|---|
| L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]- | C15H25NO4 | 1026200-27-0 | Details |
| Ammelide | C3H4N4O2 | 645-93-2 | Details |
| Ledipasvir intermediate | C24H34BN3O4 | 1256387-87-7 | Details |
| Daclatasvir | C40H50N8O6 | 1009119-64-5 | Details |
| Velpatasvir API | C49H54N8O8 | 1377049-84-7 | Details |
| Velpatasvir intermediate | C19H15BrO3 | 1378390-29-4 | Details |
| Daclatasvir intermediate | C16H12Cl2O2 | 24860-53-5 | Details |
| Ledipasvir intermediate | C29H29BrF2N4O3 | 1256388-50-7 | Details |
| Velpatasvir intermediate | C44H53N7O7 | 1378391-45-7 | Details |
| (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester | C13H20N2O4S | 401564-36-1 | Details |
| [5-Bromo-3-[(1R)-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-yl]amine | C13H10BrCl2FN2O | 877399-00-3 | Details |
| Crizotinib intermediate | C19H32BN3O4 | 877399-74-1 | Details |
| Gatifloxacin API | C19H22FN3O4 | 112811-59-3 | Details |
| Lubiprostone API | C20H32F2O5 | 136790-76-6 | Details |
| Lurasidone Hydrochloride API | C28H37ClN4O2S | 367514-88-3 | Details |
| Trelagliptin Succinate API | C22H26FN5O6 | 1029877-94-8 | Details |
| Vilazodone hydrochloride API | C26H28ClN5O2 | 163521-08-2 | Details |
| Ledipasvir API | C52H60F2N8O7 | 1441674-54-9 | Details |
| Ledipasvir solid dispersion in copovidone | Details |
| Voxilaprevir intermediate;GS9857 | C21H32N2O4 | 1799733-54-2 | Details |
| Velpatasvir solid dispersion with copovidone | Details |
| Daclatasvir API | C40H51ClN8O6 | 1009119-65-6 | Details |
| Treprostinil | C23H34O5 | 81846-19-7 | Details |
| Treprostinil Sodium API | C23H35NaO5 | 289480-64-4 | Details |
| Bimatoprost API | C25H37NO4 | 155206-00-1 | Details |
| Latanoprost API | C26H40O5 | 130209-82-4 | Details |
| (1R,2R)-1-amino-2-(difluoromethyl)-N-(1-methylcyclopropylsulfonyl) cyclopropanecarboxamide hydrochloride | C9H15ClF2N2O3S | 1360828-80-3 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||